MateRials and Methods
A prospective observational study was conducted, including all consecutive adults between 30 and 80 years with idiopathic Parkinson's who attended the Outpatient Department of Neurology of our tertiary care teaching hospital in Northern India, between July 1, 2016 and June 30, 2017. PD was diagnosed by the United Kingdom Parkinson's Disease Society Brain Bank Criteria. [9] Neurological disease severity was assessed using the Hoehn and Yahr (H and Y) staging. [10] The H and Y classifications were split into two groups (mild/moderate PD H and Y: 0-2.5 and severe PD H and Y: >3). Patients with diabetes, renal disorders, congestive heart failure, secondary PD, protein-energy malnutrition, and malignancy were excluded from the study. Age-and gender-matched control population without any disease influencing the nutritional status was also enrolled. The controls were preferably the members from the patient's family so as to have uniformity in socioeconomic status, culture, and eating patterns.
Each patient was assessed through a clinical history, where data were obtained regarding demographic information, disease symptoms, drug intake/treatment history (daily medication dosage was expressed as levodopa equivalent dose [LED]), and data on GI symptoms. N u t r i t i o n a l s t a t u s a s s e s s m e n t w a s d o n e u s i n g (1) anthropometrics -(a) weight (to the nearest 0.1 kg using calibrated weighing scale), (b) height (to the nearest cm using common measuring scale), (c) body mass index (BMI) -weight (kg)/height² (cm) where BMI of <18.5 kg/m² was considered as undernutrition, 18.5-22.9 as normal, 23-−24.9 as overweight, 25-29.9 as preobese, and >30 as obese as per the WHO classification for Asian population, [11] (d) mid-upper arm circumference -measured in cm at the mid-point between the olecranon and acromion process of the right arm using standard measuring tape, (e) Calf circumference -measured in cm at the point of maximum thickness at mid-calf using standard measuring tape; (2) biochemical parameters -venous blood samples were drawn for the determination of hemoglobin, total serum proteins, and serum albumin. The threshold values considered indicative of impairment in nutritional status were hemoglobin <11 g/dl, total serum proteins <6 g/dl, and albumin <3.5 g/dl. [12] Patients fulfilling all three criteria were considered malnourished; (3) Mini-Nutritional Assessment (MNA) Scale -a well-validated scale that was used as an additional nutritional assessment tool. [13] MNA scale has two parts, Part 1 -the screening tool and Part 2 -total MNA for nutritional assessment. The total score of 30 from 18 questions within four assessment categories (anthropometric, global, dietary, and subjective) was done to classify respondents into one of three categories: Normal nutritional status (>24), at risk of undernutrition (17-23.5) , and malnourished (<17) [Appendix 1]. [13] We divided the study population into two groups, that is Group I with abnormal nutritional status (those at risk of malnutrition as well as malnourished) whose MNA score was <23.5 and Group II with normal nutritional status whose MNA score >24 [ Figure 1 ]. GI symptoms of nutritional interest studied were dysphagia, sialorrhea, and chronic constipation. Dysphagia was assessed by Swallowing Disturbance Questionnaire [Appendix 2] [14] which includes 14 items, each with a score ranging from 0 to 3, except one question with a score ranging from 0.5 to 2.5. The total score varies between 0.5 and 44·5. A score 0.5 means that the patients experience some degree of difficulty in swallowing and a score >2 was arbitrarily considered as threatening. A cutoff score >11 was considered for the diagnosis of dysphagia needing treatment. Sialorrhea was assessed by Sialorrhea Clinical Scale for PD [Appendix 3]. [15] The scale consists of seven questions, each with a score ranging from 0 to 3, resulting in a total score of 0-21. A cutoff score of >11 was suggested for the diagnosis of sialorrhea needing treatment; however, any score higher than 0 meant that the patient had sialorrhea. Chronic constipation was assessed by ROME III Criteria [Appendix 4]. [16] Patients were diagnosed with functional constipation if they scored >2 points answering this questionnaire.
Continuous data were expressed as mean ± standard deviation. Categorical variables were expressed as percentage. Comparison between the control and cases were made using paired t-test and Mann-Whitney U-test for nonparametric data. Categorical variables were compared by Chi-square test. Groups were compared by Students t-test and value of P < 0.05 was considered as statistically significant. Analyses were performed using a spreadsheet program (Excel 2010, Microsoft and a statistical software package).
Results
Seventy-five PD patients were studied along with 35 controls. Forty PD patients were male (53.3%) and 35 (46.6%) were female, while in the control group, there were 18 male (51.5%) and 17 female (48.5%). The mean age of the study group and control group was 63 + 10.5 years and 62 + 9.46 years, respectively. According to the severity of the disease, 41.3% had mild-to-moderate disease (H and Y stage: 0-2.5) and remaining 58.6% had advanced disease (H and Y > 3). Table 1 shows the demographic and clinical characteristics of the studied subjects and controls.
According to anthropometric criteria, 23% of the PD population was underweight, and 26.6% were preobese/obese according to the WHO parameters for Asian countries. The remaining 50% were normal as compared to 43% of the controls that were normal [ Figure 2a ]. The anthropometric criteria detected 5.7% (2 patients) malnourishment in the control group.
According to biochemical assessment, 17.3% (13 patients) of the PD patients had hypoalbuminemia along with anemia as compared to 8.5% (3 patients) in the control group.
According to MNA scale for nutritional assessment, among the 75 PD patients, 9 (12%) were malnourished and 34 (45.3%) were at risk of malnutrition. Hence, a total of 43 (57.3%) patients in Group I (with abnormal nutrition) as compared to 5 patients (14%) of the control population were at risk of malnutrition while none of them was found to be malnourished [ Figure 2b ]. Table 2 shows the demographic profile, disease severity, and characteristics and GI symptoms among Group I and Group II. The mean age of Group I was 64 + 9.5 years and Group II was 62 + 10.5 years. Twenty-seven patients were male (62.7%) and 16 (37.2%) were female, while in Group II, there were 20 male (62.5%) and 12 female (37.5%). The disease duration was comparable in both the groups. Twenty-five percent of patients in Group I had mild-to-moderate disease (H and Y stage 0-2.5) as compared to 56.5% patients in Group II. On the other hand, 32 patients (74.4%) in Group I had advanced disease (H and Y >3) as compared to 34.3% patients in Group II. This difference was statistically significant. The LED of Group I was 585.91 while that of Group II was 512.21. The number of falls as reported by the UPDRS score >3 was much higher in Group I (27.9%) as compared to Group II (4.65%) and this difference was statistically significant. In our study, there was no correlation of nutritional status according to MNA with respect to age (P = 0.826), gender (P = 0.903), duration of disease (P = 0.8312), and LED (P = 0.43).
We also compared the nutritional status with regard to the presence of nonmotor GI symptoms. Among the PD patients, the symptoms of constipation, dysphagia, and sialorrhea were present in 31 patients (41.3%), 22 patients (29.3%), and 22 patients (29.3%), respectively, as compared to 1 person (2.8%) in the control group who had constipation and dysphagia each and none had sialorrhea. On comparison of the gastrointestinal symptoms within the two MNA groups in the PD population, constipation (P = 0.0042), dysphagia (P = 0.00081), and sialorrhea (P = 0.041) were significantly associated with Group I (at risk of malnourishment and malnourished patients) as compared to those with normal nutritional status (MNA >24), as shown in Table 2 .
discussion
India is a developing country with high prevalence of malnutrition. Patients with Parkinson's disease are at more risk of malnutrition, but there is a scarcity of data from India regarding nutritional assessment of PD patients. Malnutrition results in poor health outcomes and it remains underrecognized and underdiagnosed in the community. Hence, it was worthwhile to find the trends of malnutrition in a cohort of PD patients versus the normal community-dwelling population. To the best of our knowledge, this is the first study from India on the nutritional problems prevalent in PD patients.
Different studies from Western literature have reported the prevalence of malnutrition in patients with PD ranging from 3% to 60%. [17, 18] This wide variation could be attributed to the differences in methodology, criteria of classification of weight loss and malnutrition, or characteristics of the patient studied. We used three assessment tools for the diagnosis of malnutrition-anthropometric criteria, biochemical Figure 3 ].
Using anthropometric criteria as an indicator of nutritional risk in general population is historically accepted, but its use in older population, the cutoff value is debatable. [19] The risk of mortality decreases with increasing BMI in older age, and hence, using the same cutoff to diagnose malnutrition may lead to inaccurate results. Furthermore, it has been recently proposed that due to ethnic differences Asians have higher weight-related disease risks at lower BMIs; hence separate classifications have been proposed. Second, clinically significant weight loss may sometimes not result in change in BMI classification, decreasing its sensitivity as a tool for detecting malnutrition. Patients at risk of malnourishment or malnourished may be classified as overweight or obese according to BMI. Barichella et al. reported 0% as underweight, 40.8% as overweight, and 25% as obese according to BMI classification, whereas MNA score resulted in detection of 22% patients at risk of malnutrition in the same group of PD patients. Third, changes in BMI can be masked by decrease in height that occurs in PD patients as a result of osteoporosis which is quiet prevalent in this group. Finally, measurement of height for calculation of BMI is also sometimes difficult in the PD patients who have poor balance, rigidity, and are confined to wheelchair or are bedridden. Considering all these reasons, depending on anthropometric criteria alone as a tool for diagnosing malnutrition may result in fewer people being detected as malnourished.
MNA Score is a validated nutritional assessment tool that has high sensitivity and specificity for predicting nutritional status as compared to a single tool. [20] It is a wholistic tool that incorporates anthropometry, weight loss, dietary intake, and physical signs of malnutrition. The clinical guidelines for nutritional support in adults published by the National Institute for Health and Clinical Excellence recommend the use of variety of parameters when accessing malnutrition because anyone is not sufficiently sensitive. [21] Although these tools have been validated in other populations, they have not been specifically validated for use in PD patients. A systemic review published recently reports that only 2 out of the 11 reviews used MNA and 20% and 34% of the participants were at risk of malnutrition (MNA score >17), while only 2% and 0% were malnourished (MNA score <17). [22] Hence, our results are coherent with other studies that suggest that anthropometric or biochemical measures alone cannot identify all the malnourished population, but a multifactorial approach to the diagnosis including recent weight loss, dietary intake, nutrition impact symptoms along with assessment of muscle, and fat status is a valid approach for the true detection of malnourishment. MNA as a nutritional assessment tool is applicable to any age as it includes weight changes, physical examination, and presence of symptoms likely to influence intake in people with PD. Fereshtehnejad et al. used MNA scale and reported that more than a quarter of PD population was at risk of malnutrition, necessitating more attention toward nutritional assessment in PD. [23] In our results also, 57.3% had abnormal nutritional status where 12% were malnourished and 45.3% were at risk of malnutrition as per MNA score whereas incidence of abnormal nutrition was only 14% in controls.
The combination of number of factors may lead to poor intake in PD patients and hence are at greater nutritional risk. There was statistically significant relation of GI symptoms such as constipation, dysphagia, and sialorrhea with malnutrition in PD patients in our study. Park et al. have shown that GI symptoms such as constipation, dysphagia, sialorrhea, and weight loss were significantly more frequent in more severe PD patients. [24] While there is limited research on the predictors of malnutrition, Wang et al. have reported that constipation and depression are significant predictors of malnutrition. [25] GI disturbances are common in PD and virtually affect all levels of the GIT. GI symptoms in PD can be the result of both motor and nonmotor impairment. Contrary to the belief, GI disturbances are seen early in the course of the disease and constipation is one of the earliest manifestations that can precede the motor symptoms in PD patients by years. [26] Dysphagia or difficulty in swallowing food or liquid can make PD population prone to increased risk of aspiration. GI symptoms such as sialorrhea are not only incapacitating but also distressing for the patient. Hence, clinicians should pay due attention to these GI symptoms during evaluation of PD patients. These should be timely identified and promptly treated so as to reduce the risk of associated complications like malnutrition and hence increased morbidity.
Our study results need to be interpreted with caution as they are the results of a single center with small study group. Second, majority of patients in our study population fell within H and Y stage >3, patients with severe disability could not attend the OPD due to disability, so our study population may inadequately reflect the effects of severe motor disability on GI symptoms. Third, due to the geographical location of our center, most of our patients belonged to urban areas. People in rural areas may have limited access to medical facilities. Finally, most of our assessment was questionnaire based, therefore, the study has a limitation of recall bias.
conclusions
We may say that PD is an independent risk factor for malnutrition as incidence of abnormal nutrition was significantly higher in cases than control population. MNA has higher sensitivity and specificity for predicting nutritional status in PD. Appropriate identification and intervention for malnutrition may prevent/delay the associated poor outcomes. Hence, it is important to screen for malnutrition at the time of PD diagnosis and on follow-up.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
aPPendiX1. Mini nutRitional assessMent scale
Screening A. Has food intake declined over the past three months due to loss of appetite, digestive problems, chewing or swallowing difficulties? 0 = Severe decrease in food intake 1 = Moderate decrease in food intake 2 = No decrease in food intake □ B. Weight loss during the last 3 months? 0 = Weight loss greater than 3 kg (6. 
aPPendiX 4.RoMe iii diagnostic cRiteRia foR functional constiPation
Symptom onset more than 6 months prior to the diagnosis, with the following criteria fulfilled for the past 3 months: 1. Two or more of the following criteria must be met: b. Less than three bowel movements per week c. Manual maneuvers necessary to facilitate defecation more than 25% of the time. d. Hard or lumpy stools more than 25% of the time e. Sensation of incomplete evacuation more than 25% of the time f. Sensation of anorectal obstruction more than 25%of the time g. Straining with defecation more than 25% of the time 2. Loose stools rarely present without the use of laxatives 3. Insufficient criteria met to establish a diagnosis of irritable bowel syndrome
